Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
J Vis Exp ; (179)2022 01 19.
Article in English | MEDLINE | ID: mdl-35129164

ABSTRACT

Chemicals synthesized by plants, fungi, bacteria, and marine invertebrates have been a rich source of new drug hits and leads. Medicines such as statins, penicillin, paclitaxel, rapamycin, or artemisinin, commonly used in medical practice, have been first identified and isolated from natural products. However, the identification and isolation of biologically active specialized metabolites from natural sources is a challenging and time-consuming process. Traditionally, individual metabolites are isolated and purified from complex mixtures, following the extraction of biomass. Subsequently, the isolated molecules are tested in functional assays to verify their biological activity. Here we present the use of cellular membrane affinity chromatography (CMAC) columns to identify biologically active compounds directly from complex mixtures. CMAC columns allow for the identification of compounds interacting with immobilized functional transmembrane proteins (TMPs) embedded in their native phospholipid bilayer environment. This is a targeted approach, which requires knowing the TMP whose activity one intends to modulate with the newly identified small molecule drug candidate. In this protocol, we present an approach to prepare CMAC columns with immobilized tropomyosin kinase receptor B (TrkB), which has emerged as a viable target for drug discovery for numerous nervous system disorders. In this article, we provide a detailed protocol to assemble the CMAC column with immobilized TrkB receptors using neuroblastoma cell lines overexpressing TrkB receptors. We further present the approach to investigate the functionality of the column and its use in the identification of specialized plant metabolites interacting with TrkB receptors.


Subject(s)
Protein Kinases , Cell Line , Cell Membrane/metabolism , Chromatography, Affinity/methods , Protein Kinases/metabolism
2.
J Pharm Biomed Anal ; 210: 114553, 2022 Feb 20.
Article in English | MEDLINE | ID: mdl-34968995

ABSTRACT

The use of natural products has been shown to be a fruitful approach in the discovery of novel pharmaceuticals. In fact, many currently approved drugs originated from compounds that were first identified in nature. Chemical diversity of natural compounds cannot be matched by man-made libraries of chemically synthesized molecules. Many natural compounds interact with and modulate regulatory protein targets and can be considered evolutionarily-optimized drug-like molecules. Despite this, many pharmaceutical companies have reduced or eliminated their natural product discovery programs in the last two decades. Screening natural products for pharmacologically active compounds is a challenging task that requires high resource commitment. Novel approaches at the early stage of the drug discovery pipeline are needed to allow for rapid screening and identification of the most promising molecules. Here, we review the possible evolutionary roots for drug-like characteristics of numerous natural compounds. Since many of these compounds target evolutionarily conserved cellular signaling pathways, we propose novel, early-stage drug discovery approaches to identify drug candidates that can be used for the potential prevention and treatment of neurodegenerative diseases. Invertebrate in vivo animal models of neurodegenerative diseases and innovative tools used within these models are proposed here as a screening funnel to identify new drug candidates and to shuttle these hits into further stages of the drug discovery pipeline.


Subject(s)
Biological Products , Neurodegenerative Diseases , Animals , Biological Products/therapeutic use , Drug Discovery , Humans , Neurodegenerative Diseases/drug therapy
3.
ACS Appl Bio Mater ; 4(8): 6244-6255, 2021 08 16.
Article in English | MEDLINE | ID: mdl-35006910

ABSTRACT

Brain-derived neurotrophic factor (BDNF) and its receptor tyrosine receptor kinase B (TrkB) have been shown to play an important role in numerous neurological disorders, such as Alzheimer's disease. The identification of biologically active compounds interacting with TrkB serves as a drug discovery strategy to identify drug leads for neurological disorders. Here, we report effective immobilization of functional TrkB on magnetic iron oxide nanoclusters, where TrkB receptors behave as "smart baits" to bind compounds from mixtures and magnetic nanoclusters enable rapid isolation through magnetic separation. The presence of the immobilized TrkB was confirmed by specific antibody labeling. Subsequently, the activity of the TrkB on iron oxide nanoclusters was evaluated with ATP/ADP conversion experiments using a known TrkB agonist. The immobilized TrkB receptors can effectively identify binders from mixtures containing known binders, synthetic small molecule mixtures, and Gotu Kola (Centella asiatica) plant extracts. The identified compounds were analyzed by an ultrahigh-performance liquid chromatography system coupled with a quadrupole time-of-flight mass spectrometer. Importantly, some of the identified TrkB binders from Gotu Kola plant extracts matched with compounds previously linked to neuroprotective effects observed for a Gotu Kola extract approved for use in a clinical trial. Our studies suggest that the possible therapeutic effects of the Gotu Kola plant extract in dementia treatment, at least partially, might be associated with compounds interacting with TrkB. The unique feature of this approach is its ability to fast screen potential drug leads using less explored transmembrane targets. This platform works as a drug-screening funnel at early stages of the drug discovery pipeline. Therefore, our approach will not only greatly benefit drug discovery processes using transmembrane proteins as targets but also allow for evaluation and validation of cellular pathways targeted by drug leads.


Subject(s)
Centella , Drug Evaluation, Preclinical , Magnetic Phenomena , Plant Extracts , Receptor Protein-Tyrosine Kinases
4.
Nanoscale ; 11(13): 6352-6359, 2019 Mar 28.
Article in English | MEDLINE | ID: mdl-30887997

ABSTRACT

The lack of suitable tools for the identification of potential drug leads from complex matrices is a bottleneck in drug discovery. Here, we report a novel method to screen complex matrices for new drug leads targeting transmembrane receptors. Using α3ß4 nicotinic receptors as a model system, we successfully demonstrated the ability of this new tool for the specific identification and effective extraction of binding compounds from complex mixtures. The formation of cell-membrane coated nanoparticles was confirmed by transmission electron microscopy. In particular, we have developed a direct tool to evaluate the presence of functional α3ß4 nicotinic receptors on the cell membrane. The specific ligand binding to α3ß4 nicotinic receptors was examined through ligand fishing experiments and confirmed by high-performance liquid chromatography coupled with diode-array detection and electrospray ionization mass spectrometry. This tool has a great potential to transform the drug discovery process focusing on identification of compounds targeting transmembrane proteins, as more than 50% of all modern pharmaceuticals use membrane proteins as prime targets.


Subject(s)
Cell Membrane/chemistry , Chromatography, High Pressure Liquid , Ferric Compounds/chemistry , Metal Nanoparticles/chemistry , Pharmaceutical Preparations/chemistry , Receptors, Nicotinic/metabolism , Spectrometry, Mass, Electrospray Ionization , HEK293 Cells , Humans , Ligands , Microscopy, Electron, Transmission , Nicotine/analysis , Pharmaceutical Preparations/analysis , Receptors, Nicotinic/chemistry , Smoke/analysis , Tobacco Products/analysis
5.
Eur J Pharm Sci ; 129: 42-57, 2019 Mar 01.
Article in English | MEDLINE | ID: mdl-30594731

ABSTRACT

The treatment of epilepsy remains difficult mostly since almost 30% of patients suffer from pharmacoresistant forms of the disease. Therefore, there is an urgent need to search for new antiepileptic drug candidates. Previously, it has been shown that 4-alkyl-5-substituted-1,2,4-triazole-3-thione derivativatives possessed strong anticonvulsant activity in a maximal electroshock-induced seizure model of epilepsy. In this work, we examined the effect of the chemical structure of the 1,2,4-triazole-3-thione-based molecules on the anticonvulsant activity and the binding to voltage-gated sodium channels (VGSCs) and GABAA receptors. Docking simulations allowed us to determine the mode of interactions between the investigated compounds and binding cavity of the human VGSC. Selected compounds were also investigated in a panel of ADME-Tox assays, including parallel artificial membrane permeability assay (PAMPA), single cell gel electrophoresis (SCGE) and cytotoxicity evaluation in HepG2 cells. The obtained results indicated that unbranched alkyl chains, from butyl to hexyl, attached to 1,2,4-triazole core are essential both for good anticonvulsant activity and strong interactions with VGSCs. The combined in-vivo, in-vitro and in-silico studies emphasize 4-alkyl-5-substituted-1,2,4-triazole-3-thiones as promising agents in the development of new anticonvulsants.


Subject(s)
Anticonvulsants/chemistry , Anticonvulsants/pharmacology , Triazoles/chemistry , Triazoles/pharmacology , Voltage-Gated Sodium Channels/metabolism , Animals , Cell Line , Cell Line, Tumor , Cell Membrane Permeability/drug effects , Computer Simulation , Electroshock/methods , HEK293 Cells , Hep G2 Cells , Humans , Mice , Molecular Docking Simulation/methods , Receptors, GABA-A/metabolism , Seizures/drug therapy
6.
J Agric Food Chem ; 62(37): 9088-94, 2014 Sep 17.
Article in English | MEDLINE | ID: mdl-25152006

ABSTRACT

The research aims to indicate which of the structural elements of monoterpenes are responsible for their antioxidant activity. The activity was determined spectrophotometrically with the use of the DPPH(•) assay. It has been shown that π bonds are responsible for the chain-breaking antioxidant activity of monoterpenes. It has been proved, for the first time, that blocking of conjugated double bonds leads to a decrease of the antioxidant activity of monoterpenes. A probable reaction mechanism between monoterpenes and DPPH(•) has been proposed. It has been indicated that the antioxidant activity of monoterpenes strongly depends on the polarity of solvent used in the experiments. The presented results may stimulate additional research in the field of terpenoid antioxidants.


Subject(s)
Antioxidants/chemistry , Monoterpenes/chemistry , Oils, Volatile/chemistry , Terpenes/chemistry , Biphenyl Compounds/chemistry , Free Radical Scavengers/chemistry , Picrates/chemistry , Solvents/chemistry
7.
Acta Pol Pharm ; 67(5): 481-5, 2010.
Article in English | MEDLINE | ID: mdl-20873415

ABSTRACT

Thin-layer chromatographic method, with postchromatographic derivatization, was applied for the purposes of the quality control of pharmaceutical preparations, containing S. officinalis L. extract. Six finished products underwent the analysis: capsules, tablets, two ointments, tincture and finished product being a mixture of ethanolic S. officinalis and Thymi vulgaris extracts. Chromatographic and free radical scavenging fingerprints, obtained for the herbal products, were compared with the profiles of the authenticated botanical reference material. The application of the proposed technique revealed most of the fingerprints, developed for the analyzed preparations, matched with the profiles obtained for authenticated plant material. The developed method was found suitable for the quality control of herbal preparations containing sage extract.


Subject(s)
Chromatography, Thin Layer/methods , Free Radical Scavengers/analysis , Plant Extracts/analysis , Salvia officinalis/chemistry , Quality Control
SELECTION OF CITATIONS
SEARCH DETAIL
...